4//SEC Filing
Fages Herve 4
Accession 0001604643-22-000068
CIK 0001604643other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 4:30 PM ET
Size
19.5 KB
Accession
0001604643-22-000068
Insider Transaction Report
Form 4
Fages Herve
Executive Vice President
Transactions
- Exercise/Conversion
Common Stock
2022-03-08$13.91/sh+12,381$172,220→ 53,696 total - Exercise/Conversion
Common Stock
2022-03-09$13.91/sh+20,347$283,027→ 61,662 total - Sale
Common Stock
2022-03-09$43.00/sh−36,712$1,578,616→ 45,594 total - Sale
Common Stock
2022-03-08$43.00/sh−12,381$532,398→ 41,315 total - Exercise/Conversion
Common Stock
2022-03-09$23.63/sh+20,644$487,818→ 82,306 total - Sale
Common Stock
2022-03-09$44.00/sh−4,279$188,276→ 41,315 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-09$13.91/sh−20,347$283,027→ 27,023 totalExercise: $13.91Exp: 2029-03-01→ Common Stock (20,347 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-08$13.91/sh−12,381$172,220→ 47,370 totalExercise: $13.91Exp: 2029-03-01→ Common Stock (12,381 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-09$23.63/sh−20,644$487,818→ 20,644 totalExercise: $23.63Exp: 2030-02-14→ Common Stock (20,644 underlying)
Footnotes (5)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2022.
- [F2]The amount of these securities includes 34,076 unvested restricted stock units in respect of the issuer's common stock.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.0000 to $43.0100, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]This option vests in four equal installments, three of which occurred on each of March 1, 2020, March 1, 2021, and March 1, 2022, and one of which will occur on March 1, 2023, subject to the reporting person's continued employment with the issuer through such date.
- [F5]This option vests in four equal installments, two of which occurred on each of January 1, 2021 and January 1, 2022, and two of which will occur on January 1, 2023 and January 1, 2024, subject to the reporting person's continued employment with the issuer through such dates.
Documents
Issuer
Evoqua Water Technologies Corp.
CIK 0001604643
Entity typeother
Related Parties
1- filerCIK 0001768653
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 4:30 PM ET
- Size
- 19.5 KB